T. Rowe Price Associates’s Pear Therapeutics, Inc. Class A Common Stock PEAR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-11,499	Closed	-$3K	–	3031
2023 Q1	$3K	Hold	11,499	–	–	﹤0.01%	2918
2022 Q4	$14K	Buy	11,499 +1,099	+11%	+$1.34K	﹤0.01%	2888
2022 Q3	$22K	Buy	+10,400	New	+$22K	﹤0.01%	2907